Insider trading

Period: 120 months Stock: TNGX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

86 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

86 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

86 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

86 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
86 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
86 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

86 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
1 Oct 2026
Crystal Adam President, R&D
Sold on a plan 2×
$660.80K 27,000 at 24.47
18.9%
Planned (10b5-1)
22 Sep 2026
Newcomb Jessica Principal Accounting Officer
Sold on a plan 3×
$198.61K 8,200 at 24.22
12.2%
Planned (10b5-1)
1 Sep 2026
Crystal Adam President, R&D
Sold on a plan
$603.91K 27,000 at 22.37
18.9%
Planned (10b5-1)
3 Aug 2026
Crystal Adam President, R&D
Sold on a plan 2×
$735.52K 27,000 at 27.24
18.9%
Planned (10b5-1)
1 Jul 2026
Crystal Adam President, R&D
Sold on a plan 2×
$798.91K 27,000 at 29.59
18.9%
Planned (10b5-1)
1 Jun 2026
Crystal Adam President, R&D
Sold on a plan 2×
$617.57K 27,000 at 22.87
18.9%
Planned (10b5-1)
1 May 2026
Crystal Adam President, R&D
Sold on a plan 2×
$573.10K 27,000 at 21.23
18.9%
Planned (10b5-1)
15 Apr 2026
Crystal Adam President, R&D
Sold on a plan
$961.50K 38,460 at 25.00
25.5%
Planned (10b5-1)
1 Apr 2026
Crystal Adam President, R&D
Sold on a plan
$572.48K 27,000 at 21.20
19.3%
Planned (10b5-1)
25 Mar 2026
Crystal Adam President, R&D
Sold on a plan
$241.32K 12,000 at 20.11
9.6%
Planned (10b5-1)
5 Mar 2026
Crystal Adam President, R&D
Sold on a plan
$303.77K 20,251 at 15.00
15.2%
Planned (10b5-1)
25 Feb 2026
Crystal Adam President, R&D
Sold on a plan
$694.21K 54,345 at 12.77
29.0%
Planned (10b5-1)
3 Feb 2026
Weber Barbara Director, Executive Chair
Sold at will 2×
$374.29K 30,519 at 12.26
1.8%
Not planned
3 Feb 2026
Crystal Adam President, R&D
Sold at will 2×
$226.30K 18,452 at 12.26
9.0%
Not planned
3 Feb 2026
Beckman Daniella Chief Financial Officer
Sold at will 2×
$126.53K 10,317 at 12.26
5.3%
Not planned
23 Oct 2025
Sold at will
$4.85M 477,401 at 10.15
3.4%
Not planned
25 Sep 2025
Sold at will
$4.01M 500,000 at 8.02
3.5%
Not planned
16 Sep 2025
Sold at will
$2.56M 363,541 at 7.04
2.5%
Not planned
8 Sep 2025
Sold at will
$608.63K 86,459 at 7.04
0.6%
Not planned
5 Sep 2025
Sold at will
$4.50M 642,906 at 7.00
4.2%
Not planned
22 Aug 2025
Sold at will
$2.12M 302,194 at 7.00
1.9%
Not planned
19 Aug 2025
Sold at will
$7.71M 1,100,000 at 7.01
6.5%
Not planned
5 Feb 2025
Weber Barbara Chief Executive Officer
Sold at will
$28.49K 9,013 at 3.16
0.6%
Not planned
5 Feb 2025
Crystal Adam See Remarks
Sold at will
$21.66K 6,851 at 3.16
4.2%
Not planned
5 Feb 2025
Beckman Daniella Chief Financial Officer
Sold at will
$12.48K 3,948 at 3.16
2.6%
Not planned
5 Feb 2025
Barry Douglas General Counsel
Sold at will
$8.08K 2,556 at 3.16
3.7%
Not planned
4 Feb 2025
Weber Barbara Chief Executive Officer
Sold at will
$29.22K 9,778 at 2.99
0.6%
Not planned
4 Feb 2025
Crystal Adam See Remarks
Sold at will
$22.21K 7,432 at 2.99
4.3%
Not planned
4 Feb 2025
Beckman Daniella Chief Financial Officer
Sold at will
$12.80K 4,284 at 2.99
2.7%
Not planned
4 Feb 2025
Barry Douglas General Counsel
Sold at will
$8.29K 2,774 at 2.99
3.9%
Not planned
18 Nov 2024
Rothenberg Mace Director
Bought
$37.80K 10,000 at 3.78
47.1%
Largest buy in 3 yrs
14 Nov 2024
Rothenberg Mace Director
Bought
$36.20K 10,000 at 3.62
88.9%
First buy on file
7 Nov 2024
EcoR1 Capital, LLC 10% owner · indirect
Sold at will 2×
$3.54M 1,205,442 at 2.94
10.2%
Not planned
6 Nov 2024
Boxer Capital Management, LLC See remarks · indirect
Sold at will
$9.67M 3,080,000 at 3.14
46.0%
Not planned
6 Nov 2024
EcoR1 Capital, LLC 10% owner · indirect
Sold at will
$4.90M 1,494,558 at 3.28
11.2%
Not planned
25 Oct 2024
Sold at will
$4.35M 633,000 at 6.87
8.6%
Not planned
22 Oct 2024
Sold at will
$1.70M 250,000 at 6.78
3.3%
Not planned
21 Oct 2024
Sold at will
$4.41M 625,000 at 7.05
7.6%
Not planned
13 Sep 2024
Sold at will
$709.76K 67,400 at 10.53
0.4%
Not planned
5 Sep 2024
Sold at will
$867.14K 75,000 at 11.56
0.4%
Not planned
30 Aug 2024
Sold at will
$2.03M 175,000 at 11.60
1.0%
Not planned
27 Aug 2024
Sold at will
$288.67K 25,000 at 11.55
0.1%
Not planned
19 Aug 2024
Sold at will
$1.51M 150,000 at 10.09
0.9%
Not planned
16 Aug 2024
Sold at will
$1.32M 135,000 at 9.79
0.8%
Not planned
1 Aug 2024
Sold at will
$392.00K 40,000 at 9.80
0.2%
Not planned
31 Jul 2024
Sold at will
$993.38K 100,000 at 9.93
0.6%
Not planned
30 Jul 2024
Sold at will
$931.11K 95,000 at 9.80
0.5%
Not planned
26 Jul 2024
Sold at will
$491.95K 50,000 at 9.84
0.3%
Not planned
25 Jul 2024
Sold at will
$992.77K 100,599 at 9.87
0.6%
Not planned
24 Jul 2024
Sold at will
$1.96M 200,000 at 9.82
1.1%
Not planned
Showing 1–50 of 86. Page 1 of 2 Older →